Literature DB >> 8074462

Control of the expression of thrombospondin 1 in human breast cancer cell lines.

M Michaud1, P Poyet.   

Abstract

Thrombospondins (TSP) are adhesive glycoproteins which are synthesized, secreted and incorporated into the extracellular matrix of a variety of cells, including mammary epithelial cells. These molecules are included in a gene family that is composed of at least four members. Their roles in the mammary gland are associated with two contradictory functions: antiangiogenesis and tumor invasiveness. To define the role of TSP1 in the mammary gland, the steady-state level of TSP1 mRNA in both normal (HB100) and breast cancer cell lines (MCF-7, T47-D, MDA-MB-231, ZR-75-1) was established. We also observed that the TSP1 protein synthesis is down regulated in breast cancer cell lines as compared to the HB100 cell line. These results show that TSP1 is expressed in well differentiate cells, and suggest that TSP1 could be associated with the antiangiogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8074462

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration.

Authors:  Gema Martin-Manso; Maria J Calzada; Yoshiro Chuman; John M Sipes; Charles P Xavier; Vladimir Wolf; Svetlana A Kuznetsova; Jeffrey S Rubin; David D Roberts
Journal:  Arch Biochem Biophys       Date:  2011-03-21       Impact factor: 4.013

2.  Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.

Authors:  Jeff S Isenberg; Fuminori Hyodo; Lisa A Ridnour; Caitlin S Shannon; David A Wink; Murali C Krishna; David D Roberts
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

3.  Thrombospondin-1 might be a therapeutic target to suppress RB cells by regulating the DNA double-strand breaks repair.

Authors:  Pei Chen; Na Yu; Zhang Zhang; Ping Zhang; Ying Yang; Nandan Wu; Lijun Xu; Jing Zhang; Jian Ge; Keming Yu; Jing Zhuang
Journal:  Oncotarget       Date:  2016-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.